CVS Health: data

See data on the retailer’s performance and forecasts for its operations by channel.

IGD newsletters

Get the latest industry news and insights straight to your inbox with our range of newsletters

Insights

Retail execution at CVS Pharmacy, New York, USA

We visited CVS Pharmacy's new drugstore of the future concept in New York designed to enhance the retail customer experience. See how the retailer has created a new focus around discovery zones, healthier food ranges and an expanded beauty offer.

USA country presentation

This in-depth guide to USA explores the key trends in grocery retail and the growth strategies of the leading retailers in the country.

North America retail outlook 2019

Following a year of accelerated change in the North American grocery market, we look at the five key trends set to shape it in 2019.

Latest News

News Feature image

We look at how US food and drugstore retailers are playing a pivotal role in the distribution of COVID-19 vaccines across the country as part of the Federal Retail Pharmacy Program (FRPP).

More News

CVS Health releases third-quarter performance and announces Karen S. Lynch as the next CEO. Q3 performance driven by its diversified assets Total revenue increased by 3.5% to $67.1bn and was attributed to growth in its Retail / Long-Term Care (LTC) segment and Health Care Benefits segment. Retail/ LTC revenues grew by 5.9% to $22.7bn, driven by higher prescription volume of +4.6% and inc...
We review CVS Health’s performance in the second quarter and its latest developments to help navigate through COVID-19. Revenue growth despite being impacted by COVID-19 CVS Health reported total revenue increased by 3.0% to $USD 65.3bn for the second quarter ending 30 th June 2020. The drugstore chain reported growth despite being affected by COVID-19, with impacts on its footfall and num...
We review CVS Health’s Q1 performance and its role in relation to the coronavirus (COVID-19) pandemic. Retail same-stores sales up 9.0% Total net revenues increased 8.3% to $66.8bn in Q1, driven by higher volume in its Retail/LTC segment and pharmacy service along with membership growth in government products in health care benefits. Retail/LTC revenues were up 7.7%, with same-store sales u...

Please login to this service
to view this data

LOGIN
Data

Use our COVID-adjusted forecasts on over 400 retailers in over 180 countries